Insider trades

Michael Andrew Chambers, Director of Sarepta Therapeutics SRPT, has filed 9 purchases and 0 sales on the open market. The latest trade was on 06/04.

Michael Andrew Chambers

Director
First filing
23/03/08
Trades
18 trades
Buys / sales
9 / 0
12-month net buying
No record
Last trade
06/04

Trading activity

Transactions

Trade type
SRPT
Open-market buy24/08/1624/08/2037,038 sh3 trades$133.80avg.$4,955,728.14+15.0%
SRPT
Open-market buy23/08/1423/08/159,979 sh2 trades$109.47avg.$1,092,429.41+4.2%
Open-market buy23/08/1123/08/1423,686 sh$108.05$2,559,272.3+11.1%
SRPT
Open-market buy23/08/1023/08/1134,867 sh3 trades$106.15avg.$3,701,067.12+19.5%